Bilateral acute retinal necrosis during treatment with alemtuzumab for multiple sclerosis.

Introduction:Alemtuzumab is a humanized monoclonal antibody used as a treatment of multiple sclerosis (MS) and chronic lymphocytic leukemia. It decreases T cell count leading to significant immunos...